Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Cash dividends declared: $928M in Q4 2022, up 2.7% from a year earlier. No newer figure appears in the documents we track.
Latest, Q4 2022
928
Period ended Dec 31, 2022
Change on a year earlier
+2.7%
904 in Q4 2021
History
32 quarters
Since Q1 2015
Sources
6
Documents cited below
Where the Q4 2022 figure comes from
Source: Form 10-K (filed 2023-02-22) ↗
Reported in Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Gilead Sciences Cash dividends declared ($M), quarterly Q1 2015–Q4 2022 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/cap-div-decl-tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.